<DOC>
	<DOCNO>NCT02913794</DOCNO>
	<brief_summary>Fimasartan Rosuvastatin hypertension dyslipidemia control</brief_summary>
	<brief_title>Fimasartan Rosuvastatin Hypertension Dyslipidemia Control</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Hypertension patient take antihypertensive agent , include Fimasartan least 12 week . Dyslipidemia patient take dyslipidemia drug , include Rosuvastatin least 12 week Patients blood pressure lipid level ( Total cholesterol , LDLC , HDLC , nonHDLC , * TG ) check 2 week registration Patients hospitalize Patients stop take Fimasartan Rosuvastatin within 12 week 14 consecutive day Patients 400mg/dl triglyceride ( TG ) registration time</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>